Inkontinensia Urin

01Pathophysiology

Continence depends on a balance between bladder storage pressure and urethral closure pressure. During filling, the detrusor muscle relaxes (sympathetic beta-3 receptors and central inhibition) while the internal urethral sphincter (alpha-1 receptors) and external sphincter (somatic pudendal nerve) remain contracted. Voiding requires coordinated detrusor contraction (parasympathetic M3 receptors) with sphincter relaxation. Any disruption of this balance produces incontinence, and the type depends on which mechanism fails.

In stress incontinence, the urethral sphincter cannot withstand sudden rises in intra-abdominal pressure. Two mechanisms exist: urethral hypermobility, in which weakened pelvic floor support allows the bladder neck to descend below the pelvic floor during straining, and intrinsic sphincter deficiency, in which the sphincter itself is incompetent. Childbirth stretches the pudendal nerve and damages endopelvic fascia; estrogen loss thins the urethral mucosa and reduces submucosal vascular cushions. This is why the classic patient is a multiparous postmenopausal woman who leaks with cough, sneeze, or laughter.

In urge incontinence, the detrusor contracts involuntarily during the filling phase. This may be idiopathic (overactive bladder) or neurogenic (loss of central inhibition from stroke, multiple sclerosis, or Parkinson disease). The patient feels a sudden, overwhelming urge and leaks before reaching the toilet. Bladder irritants such as urinary tract infection, stones, or tumor can also trigger detrusor overactivity, which is why urinalysis is mandatory before labeling a patient as having idiopathic overactive bladder.

In overflow incontinence, the bladder is chronically distended and leaks small volumes once intravesical pressure exceeds urethral pressure. Two mechanisms: outlet obstruction (most often benign prostatic hyperplasia in men) or detrusor underactivity (diabetic autonomic neuropathy, spinal cord injury below the conus, anticholinergic medications). The bladder becomes a passive reservoir that overflows when full, producing continuous dribbling and a palpable suprapubic mass.

In functional incontinence, the urinary tract is intact but the patient cannot reach the toilet in time because of cognitive impairment, immobility, or environmental barriers. This is a diagnosis of exclusion and is common in nursing home residents.

Total (continuous) incontinence results from an anatomic bypass of the sphincter mechanism. The classic causes are vesicovaginal fistula (after obstetric trauma, hysterectomy, or pelvic radiation) and ectopic ureter that empties below the sphincter. Urine leaks constantly, day and night, regardless of bladder filling or position.

02Classification of Clinical Manifestations

03Diagnostic Workup

The workup begins with a focused history that classifies the type of incontinence by its trigger. A bladder diary kept over three days documents fluid intake, voiding times, leakage episodes, and associated activities; this is often more revealing than any laboratory test. Physical examination includes a pelvic exam to assess prolapse, atrophy, and a cough stress test, plus a neurologic exam targeting the sacral reflexes (S2 to S4).

Urinalysis is the mandatory first investigation in every patient because urinary tract infection, hematuria, or glucosuria can mimic or cause incontinence. Treating an unrecognized infection often resolves apparent urge symptoms entirely.

Post-void residual is the next critical test. A residual greater than 200 mL strongly suggests overflow incontinence, whereas a normal residual (less than 50 mL) makes overflow unlikely. This single measurement separates patients who need outlet evaluation or catheterization from those who do not.

Urodynamic studies are the most accurate (gold standard) test but are not required for straightforward cases. They are reserved for diagnostic uncertainty, mixed symptoms, neurogenic causes, failure of empiric therapy, or preoperative planning. Cystometry measures the pressure-volume relationship during filling and voiding and can directly demonstrate detrusor overactivity, sphincter incompetence, or impaired contractility.

For a patient with continuous leakage, suspect a fistula or ectopic ureter. The dye test (instillation of methylene blue into the bladder with a tampon in the vagina) and CT urography or pelvic MRI confirm the anatomic defect.

04Management and Treatment

All patients begin with conservative measures: weight loss (a 5 to 10 percent reduction halves stress incontinence episodes), reduction of caffeine and alcohol, evening fluid restriction, smoking cessation, and treatment of constipation. Pelvic floor muscle training (Kegel exercises) is the cornerstone of first-line therapy for both stress and urge incontinence. The patient contracts the pelvic floor for 5 to 10 seconds, repeated 10 times, three sets daily, for at least 12 weeks before judging response.

For stress incontinence, if conservative therapy fails, a vaginal pessary can support the bladder neck mechanically. Topical vaginal estrogen restores urethral mucosal coaptation in postmenopausal women but systemic estrogen worsens incontinence and should not be used. The definitive treatment is the midurethral sling, which provides a hammock under the urethra and is the most effective long-term option.

For urge incontinence, behavioral therapy (bladder training with progressively longer voiding intervals) is tried first. If symptoms persist, antimuscarinics (oxybutynin, tolterodine, solifenacin) reduce detrusor contractions but cause dry mouth, constipation, and confusion, which limits use in older adults. Mirabegron, a beta-3 agonist, achieves similar efficacy without anticholinergic side effects and is preferred in elderly patients or those on multiple anticholinergic drugs. Refractory cases respond to intradetrusor onabotulinumtoxinA (warn patients of the risk of urinary retention requiring intermittent catheterization) or sacral neuromodulation.

For overflow incontinence, the priority is identifying and reversing the cause. Discontinue offending medications (anticholinergics, opioids, calcium channel blockers). Treat outlet obstruction: alpha-blockers relax the prostatic smooth muscle within days, while 5-alpha-reductase inhibitors shrink the gland over months. If the bladder cannot empty despite these measures, clean intermittent self-catheterization is the standard of care; a chronic indwelling catheter is avoided when possible because of infection and stone risk.

Next best step logic on the exam: for any patient presenting with new urinary incontinence, the first action is urinalysis to exclude infection. For an elderly man with overflow and a palpable bladder, the next step is bladder catheterization for relief before any imaging or pharmacology. For a young multiparous woman with classic stress symptoms, the next step is pelvic floor exercises, not urodynamics or surgery.

Contraindications: Antimuscarinics are contraindicated in narrow-angle glaucoma, gastric retention, and significant urinary retention, and should be avoided in patients with dementia (worsens cognition). Mirabegron should be used cautiously in uncontrolled hypertension. Estrogen therapy is contraindicated in breast cancer survivors. Surgery is generally deferred until after childbearing is complete.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common error is anchoring on the type of incontinence without first excluding reversible causes. Every patient with new incontinence needs a urinalysis and a medication review before being labeled as having stress, urge, or overflow disease. A nursing home resident who suddenly develops incontinence has delirium, infection, or stool impaction until proven otherwise; the mnemonic DIAPPERS (Delirium, Infection, Atrophic vaginitis, Pharmaceuticals, Psychological, Excess urine output, Restricted mobility, Stool impaction) captures the reversible contributors.

The second trap is confusing urge with overflow in an elderly man who reports frequency and leakage. Both produce involuntary urine loss, but the pathophysiology is opposite: urge from an overactive bladder, overflow from a bladder that cannot empty. Giving an antimuscarinic to a man with overflow precipitates acute urinary retention. The discriminator is the post-void residual, which is why this measurement is mandatory in any patient with leakage and a palpable bladder, weak stream, or hesitancy.

A third trap is the continuous leakage vignette. When a young woman reports constant dampness day and night, the answer is not stress or urge incontinence; it is a fistula or ectopic ureter. Look for the temporal clue: recent hysterectomy, obstetric injury, or pelvic radiation points to a fistula, while lifelong symptoms point to an ectopic ureter.

A fourth trap concerns drug therapy in older adults. Oxybutynin is highly anticholinergic and worsens cognition, dry mouth, and constipation; in a frail elderly patient, mirabegron is the safer choice. Likewise, systemic estrogen worsens incontinence and is the wrong answer; topical vaginal estrogen is the correct choice for atrophic vaginitis contributing to symptoms.

The core competency tested is classifying the type of incontinence from the trigger, excluding reversible causes with urinalysis and post-void residual, and selecting therapy that matches the mechanism. Stress leaks with Valsalva and is treated with pelvic floor exercises and slings. Urge leaks with sudden urgency and is treated with bladder training and bladder-relaxing drugs. Overflow leaks because the bladder cannot empty and is treated by relieving obstruction or catheterization. Continuous leakage means an anatomic bypass and requires surgical correction. Get the type right, and the management follows directly.